DrugPatentWatch Database Preview

Drugs in Development Information for PTC299

« Back to Dashboard

Summary for PTC299

US Patents	58
International Patents	601
US Patent Applications	43
WIPO Patent Applications	38
Japanese Patent Applications	0
Clinical Trial Progress	Phase 1 (2009-07-01)
Vendors	40

US Patents for PTC299

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
PTC299		Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors	SmithKline Beecham Corporation (Philadelphia, PA)
PTC299		Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and corresponding thiazines	SmithKline Beckman Corporation (Philadelphia, PA)
PTC299		Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors	SmithKline Beecham Corp. (Philadelphia, PA)
PTC299		Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages	SmithKline Beecham Corp. (Phildelphia, PA)
PTC299		Anti-inflammatory compounds	SmithKline Beecham Corp. (Philadelphia, PA)
PTC299		Anti-inflammatory compounds	SmithKline Beecham Corp. (Philadelphia, PA)
PTC299		Anti-inflammatory compounds	SmithKline Beecham Corp. (Philadelphia, PA)

International Patents for PTC299

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
PTC299	Austria	110387	2005-05-23
PTC299	Austria	122044	2005-05-23
PTC299	Austria	84037	2005-05-23
PTC299	Australia	1815092	2005-05-23
PTC299	Australia	2174488	2005-05-23
PTC299	Australia	4506489	2005-05-23
PTC299	Australia	5780186	2005-05-23